Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients

por Yahua Wu, Haishan Wu, Mingqiang Lin, Tianxiu Liu, Jiancheng Li
Publicado 2022

Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation

por Qunhao Zheng, Zhiping Wang, Mengyan Zhang, Yilin Yu, Rui Chen, Tianzhu Lu, Lingyun Liu, Jiayu Ma, Tianxiu Liu, Hongying Zheng, Hui Li, Jiancheng Li
Publicado 2021